Literature DB >> 10829099

Angiotensin-(1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart.

A P Almeida1, B C Frábregas, M M Madureira, R J Santos, M J Campagnole-Santos, R A Santos.   

Abstract

It has been shown that angiotensin-(1-7) (Ang-(1-7)) infusion potentiates the bradykinin (BK)-induced hypotensive response in conscious rats. The present study was conducted to identify Ang-(1-7)-BK interactions in the isolated rat heart perfused according to the Langendorff technique. Hearts were excised and perfused through the aortic stump under a constant flow with Krebs-Ringer solution and the changes in perfusion pressure and heart contractile force were recorded. Bolus injections of BK (2.5, 5, 10 and 20 ng) produced a dose-dependent hypotensive effect. Ang-(1-7) added to the perfusion solution (2 ng/ml) did not change the perfusion pressure or the contractile force but doubled the hypotensive effect of the lower doses of BK. The BK-potentiating Ang-(1-7) activity was blocked by pretreatment with indomethacin (5 mg/kg, ip) or L-NAME (30 mg/kg, ip). The Ang-(1-7) antagonist A-779 (50 ng/ml in Krebs-Ringer) completely blocked the effect of Ang-(1-7) on BK-induced vasodilation. These data suggest that the potentiation of the BK-induced vasodilation by Ang-(1-7) can be attributed to the release of nitric oxide and vasodilator prostaglandins through an Ang-(1-7) receptor-mediated mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10829099     DOI: 10.1590/s0100-879x2000000600012

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  16 in total

Review 1.  Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology.

Authors:  Carlos M Ferrario
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

2.  Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7).

Authors:  Carlos M Ferrario; Sarfaraz Ahmad; Janae Joyner; Jasmina Varagic
Journal:  Adv Pharmacol       Date:  2010

Review 3.  ACE2: more of Ang-(1-7) or less Ang II?

Authors:  Carlos M Ferrario
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-01       Impact factor: 2.894

4.  Angiotensin-(1-7): Translational Avenues in Cardiovascular Control.

Authors:  Daniela Medina; Amy C Arnold
Journal:  Am J Hypertens       Date:  2019-11-15       Impact factor: 2.689

5.  Analysis of erectile responses to bradykinin in the anesthetized rat.

Authors:  Justin A Edward; Edward A Pankey; Ryan C Jupiter; George F Lasker; Daniel Yoo; Vishwaradh G Reddy; Taylor C Peak; Insun Chong; Mark R Jones; Samuel V Feintech; Sarah H Lindsey; Philip J Kadowitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-06-08       Impact factor: 4.733

Review 6.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

7.  Modulation of cardiac L-type Ca2+ current by angiotensin-(1-7): normal versus heart failure.

Authors:  Peng Zhou; Che Ping Cheng; Tiankai Li; Carlos M Ferrario; Heng-Jie Cheng
Journal:  Ther Adv Cardiovasc Dis       Date:  2015-06-16

8.  Angiotensin-(1-7) Selectively Induces Relaxation and Modulates Endothelium-Dependent Dilation in Mesenteric Arteries of Salt-Fed Rats.

Authors:  Gábor Raffai; Julian H Lombard
Journal:  J Vasc Res       Date:  2016-09-28       Impact factor: 1.934

9.  The role of bradykinin, AT2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat.

Authors:  R Soares de Moura; A C Resende; A F Emiliano; T Tano; A C Mendes-Ribeiro; M L G Correia; L C R Marins de Carvalho
Journal:  Br J Pharmacol       Date:  2004-02-02       Impact factor: 8.739

Review 10.  The sweeter side of ACE2: physiological evidence for a role in diabetes.

Authors:  Sharell M Bindom; Eric Lazartigues
Journal:  Mol Cell Endocrinol       Date:  2008-10-01       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.